Journal
JOURNAL OF NEUROSCIENCE
Volume 33, Issue 25, Pages 10453-10458Publisher
SOC NEUROSCIENCE
DOI: 10.1523/JNEUROSCI.5875-12.2013
Keywords
-
Categories
Funding
- National Institutes of Health-National Institute of Neurological Disorders and Stroke
- National Multiple Sclerosis Society
- European Leukodystrophies Association
- National Institutes of Health-National Institute of Neurological Disorders and Stroke Center Core Grant [5 P30 NS047463]
Ask authors/readers for more resources
CNS myelination and the maturation of the myelinating cells of the CNS, namely oligodendrocytes, are thought to be regulated by molecular mechanisms controlling the actin cytoskeleton. However, the exact nature of these mechanisms is currently only poorly understood. Here we assessed the role of calcium/calmodulin-dependent kinase type II (CaMKII), in particular CaMKII beta, in oligodendrocyte maturation and CNS myelination. Using in vitro culture studies, our data demonstrate that CaMKII beta is critical for the proper morphological maturation of differentiating oligodendrocytes, an aspect of oligodendrocyte maturation that is mediated to a large extent by changes in the cellular cytoskeleton. Furthermore, our data provide evidence for an actin-cytoskeleton-stabilizing role of CaMKII beta in differentiating oligodendrocytes. Using Camk2b knock-out and Camk2b(A303R) mutant mice, our data revealed an in vivo functional role of CaMKII beta in regulating myelin thickness that may be mediated by a non-kinase-catalytic activity. Our data point toward a critical role of CaMKII beta in regulating oligodendrocyte maturation and CNS myelination via an actin-cytoskeleton-regulatory mechanism.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available